Tyler Martin

Roca, Nebraska, United States
Dr. Tyler Martin is an infectious disease physician who has been leading biotech teams an companies for nearly 30 years. He led the team at Chiron that developed FLUAD (now a Sequirus product), and led the team at Dynavax that developed HEPLISAV-B. He has also held leadership positions in gene therapy, gene editing, monoclonal antibody, and pharmaceutical companies. He joined Aeolian when the company was formed in 2022.
Speaking In
2:15 PM - 2:30 PM
Monday, June 5
Aeolian Biotech is reaching for an improved pneumococcal vaccine. Our management team includes…
Session Room 104B